After Survival Analysis we concluded that four genes (SPRY2-for Bladder cancer, CBL-for Endometrial cancer, TGFA-for Melanoma and GAB2 for Non-small cell lung cancer) were the Biomarkers for Nitroglycerin. This evidence concerns the gene CBL and urinary bladder cancer.